| __timestamp | Amphastar Pharmaceuticals, Inc. | MiMedx Group, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 51256000 | 105558000 |
| Thursday, January 1, 2015 | 77347000 | 167094000 |
| Friday, January 1, 2016 | 104189000 | 212608000 |
| Sunday, January 1, 2017 | 90795000 | 285920000 |
| Monday, January 1, 2018 | 106985000 | 322725000 |
| Tuesday, January 1, 2019 | 131923000 | 256174000 |
| Wednesday, January 1, 2020 | 143340000 | 208904000 |
| Friday, January 1, 2021 | 199739000 | 215332000 |
| Saturday, January 1, 2022 | 248860000 | 219525000 |
| Sunday, January 1, 2023 | 351121000 | 266843000 |
Data in motion
In the ever-evolving landscape of pharmaceuticals, Amphastar Pharmaceuticals, Inc. and MiMedx Group, Inc. have showcased intriguing trends in their gross profit margins over the past decade. From 2014 to 2023, Amphastar Pharmaceuticals has seen a remarkable growth trajectory, with its gross profit surging by approximately 585%, from $51 million to $351 million. This growth reflects the company's strategic advancements and market adaptability.
Conversely, MiMedx Group, Inc. experienced a more modest increase of around 153% in the same period, starting at $106 million and reaching $267 million by 2023. Despite facing challenges, MiMedx has maintained a steady upward trend, underscoring its resilience in a competitive market.
These trends highlight the dynamic nature of the pharmaceutical industry, where innovation and strategic planning are key to financial success.
Bristol-Myers Squibb Company vs MiMedx Group, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Vertex Pharmaceuticals Incorporated and MiMedx Group, Inc.
Gross Profit Trends Compared: Incyte Corporation vs MiMedx Group, Inc.
Who Generates Higher Gross Profit? Catalent, Inc. or Amphastar Pharmaceuticals, Inc.
Gross Profit Comparison: Halozyme Therapeutics, Inc. and Amphastar Pharmaceuticals, Inc. Trends
Alkermes plc vs MiMedx Group, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Amneal Pharmaceuticals, Inc. and MiMedx Group, Inc.
Gross Profit Trends Compared: Vericel Corporation vs Amphastar Pharmaceuticals, Inc.
Gross Profit Analysis: Comparing Amphastar Pharmaceuticals, Inc. and Taro Pharmaceutical Industries Ltd.
Gross Profit Comparison: Amphastar Pharmaceuticals, Inc. and Travere Therapeutics, Inc. Trends
Gross Profit Analysis: Comparing Amphastar Pharmaceuticals, Inc. and Evotec SE
Who Prioritizes Innovation? R&D Spending Compared for Amphastar Pharmaceuticals, Inc. and MiMedx Group, Inc.